Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Barbara Ann Karmanos Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Sarcoma Alliance for Research through Collaboration